# Rivaroxaban for Scheduled Work-up of DVT - The Ri-Schedule Study

Study · id `cardio:ct-nct02486445` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02486445](<https://clinicaltrials.gov/study/NCT02486445>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT02486445

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 625 participants.

## Technical summary

Registry record NCT02486445. Allocation not applicable; no masking; primary purpose treatment. Start 2015-03 (actual); primary completion 2018-11-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 625 participants (enrolled count; ClinicalTrials.gov record NCT02486445, source copy `cardio:ctgov-nct02486445-2026-11-10`, retrieved 2026-11-18)
- Started: 2015-03 (actual) (ClinicalTrials.gov record NCT02486445, source copy `cardio:ctgov-nct02486445-2026-11-10`, retrieved 2026-11-18)
- Primary completion: 2018-11-30 (actual) (ClinicalTrials.gov record NCT02486445, source copy `cardio:ctgov-nct02486445-2026-11-10`, retrieved 2026-11-18)
- Completion: 2018-12-30 (actual) (ClinicalTrials.gov record NCT02486445, source copy `cardio:ctgov-nct02486445-2026-11-10`, retrieved 2026-11-18)
- Countries: Norway (ClinicalTrials.gov record NCT02486445, source copy `cardio:ctgov-nct02486445-2026-11-10`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02486445-2026-11-10`, retrieved 2026-11-18)

## The registry's words

- Brief title: Rivaroxaban for Scheduled Work-up of DVT - The Ri-Schedule Study
- Acronym: Ri-Schedule
- Condition: Deep Venous Thrombosis
- Intervention (Drug): Rivaroxaban
- Lead sponsor: Ostfold Hospital Trust
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Deep vein thrombosis (`cardio:deep-vein-thrombosis`)
- Registry intervention name matches this record: Rivaroxaban (`cardio:rivaroxaban`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Safety of a strategy combining D-dimer testing and whole-leg ultrasonography to rule out deep vein thrombosis (`cardio:pubmed-33057634`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Clinical use and safety of empiric anticoagulation during diagnostic work-up for deep vein thrombosis (`cardio:pubmed-41116683`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: ae5f64dee18d86a33d9c852b3d0bcdf05c04bf54c3b5ee9b693b85bf7a57a90f
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
